Drawing for CULMINATION

USPTO serial 87822368

CULMINATION

Reviewed by CopyMark Law Group

Reg. 6694431Status 700Registered
Filing date
Status date
Registration date
Apr 5, 2022
Examiner
O'ROURKE, JONATHAN RYAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CULMINATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua G. Gigger

Joshua G. Gigger STOEL RIVES LLP201 SOUTH MAIN STREET, SUITE 1100SALT LAKE CITY, UT 84111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Medical research and analysis services, namely, medical laboratory research and medical laboratory services; biological research and analysis services; genetic analysis services in the nature of genetic testing for scientific research purposes; cell, cell line, tissue, tissue line and bodily fluid analysis services in the nature of medical laboratory research for scientific research purposes; scientific laboratory services in the fields of medical, health and biological data analysis; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; providing medical research and scientific research information in the fields of pathology, pharmacology, immunology, bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; preparation of biological samples for research purposes; medical laboratory services; medical and scientific laboratory services for collecting, incubating, growing, controlling, processing, analyzing, transporting and storing biological samples; operating and maintaining a biorepository for medical and scientific research purposes; laboratory services, namely, isolation, archival storage and chain-of-custody management of DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens for others; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenomics; research and development services in the nature of creating libraries and collections of DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens; computer modeling services; and computer simulation based on computer programs for others; providing online non-downloadable software for the collection, storage, management, organization, analysis, and display of data in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling for medical diagnostic and treatment research purposes; software as a service services featuring software for the collection, storage, management, organization, analysis, and display of data in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling for medical diagnostic and treatment research purposes; providing an online computer database for medical and scientific researchers in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; and development of computer software and hardware for use in medical, health and biological data analysis; analyzing and compiling data for research purposes in the field of medical science and medical consultancy; and compilation, systemization and administration of medical, health and biological data for research purposes via computer apparatus and computer databasesACTIVEFeb 17, 2022
044Gene and human tissue bank services in the nature of biological asset bank repository services for DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens; isolation, collection, preservation and banking of biological assets, namely, DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; medical analysis of biological assets, namely, DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens, for medical diagnostic and treatment purposes; providing a website featuring medical information in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; providing online non-downloadable searchable databases and non-searchable databases featuring medical information in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; providing medical information in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; genetic analysis services in the nature of genetic testing for medical purposes; and cell, cell line, tissue, tissue line and bodily fluid analysis services in the nature of genetic testing for medical purposesACTIVEFeb 17, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Apr 5, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 3, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 2, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 1, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 27, 2022IUAFUSE AMENDMENT FILED—
Feb 27, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 27, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 26, 2021EX5GSOU EXTENSION 5 GRANTED—
Aug 26, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 24, 2021EXT5SOU EXTENSION 5 FILED—
Aug 24, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 27, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 25, 2021EX4GSOU EXTENSION 4 GRANTED—
Feb 25, 2021EXT4SOU EXTENSION 4 FILED—
Feb 25, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 25, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 21, 2020EX3GSOU EXTENSION 3 GRANTED—
Aug 21, 2020EXT3SOU EXTENSION 3 FILED—
Aug 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 26, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 24, 2020EX2GSOU EXTENSION 2 GRANTED—
Feb 24, 2020EXT2SOU EXTENSION 2 FILED—
Feb 24, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 24, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 24, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 24, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 24, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 24, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 4, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 2, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 2, 2019EX1GSOU EXTENSION 1 GRANTED—
Jul 2, 2019EXT1SOU EXTENSION 1 FILED—
Jul 2, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 26, 2018ALIEASSIGNED TO LIE—
Nov 6, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 6, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Nov 6, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 6, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 6, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 5, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 4, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2018DOCKASSIGNED TO EXAMINER—
Mar 13, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 9, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance